The quintet of abdominal obesity, hypertension, dyslipidemia, abnormal glucose metabolism, and coagulopathy has been called “syndrome X” or “metabolic syndrome.” Some have referred to this grouping as the “insulin resistance syndrome,” the “obesity dyslipidemia syndrome,” and the “deadly quartet.”